Myalgia with Elevated Inflammatory Markers in an Obese Young Female: Fibromyalgia or Polymyalgia Rheumatica?
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
08 May 2019
08 May 2019
Historique:
entrez:
9
5
2019
pubmed:
9
5
2019
medline:
18
12
2019
Statut:
epublish
Résumé
BACKGROUND Fibromyalgia (FM) is a common disorder of diffuse musculoskeletal pain. It is distinctly different from polymyalgia rheumatica (PMR), a disease seen in people over the age of 50 years. Hallmark features of PMR are the presence of elevated erythrocytes sedimentation rate (ESR) and/or C-reactive protein (CRP). These markers are normal in FM. Obesity in itself can be associated with elevated CRP and ESR, and when obese patients present with myalgia and elevated inflammatory markers, diagnostic confusion can ensue. CASE REPORT We describe a case of 38-year-old female with diffuse musculoskeletal pain and elevated ESR and CRP who was initially misdiagnosed with PMR and responded partially to steroids. She developed severe adverse effects from chronic steroid use. She was ultimately diagnosed with FM. CONCLUSIONS We highlight features to help clinicians avoid the pitfall of diagnosing PMR in young obese patients with FM and elevated inflammatory markers. In this case report, we discuss the features of FM, PMR, PMR-like symptoms presentation, and the association of obesity with elevated inflammatory markers.
Identifiants
pubmed: 31064976
pii: 915564
doi: 10.12659/AJCR.915564
pmc: PMC6524750
doi:
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
659-663Références
Curr Opin Rheumatol. 2001 Jan;13(1):62-6
pubmed: 11148717
J Rheumatol. 2003 Jan;30(1):146-50
pubmed: 12508404
Diabetes Obes Metab. 2004 Jul;6(4):249-58
pubmed: 15171748
J Rheumatol. 2008 Feb;35(2):270-7
pubmed: 18050370
Can Fam Physician. 2010 Dec;56(12):1295-7, e415
pubmed: 21156893
Oman Med J. 2008 Jul;23(3):189-91
pubmed: 22359712
Ann Rheum Dis. 2012 Apr;71(4):484-92
pubmed: 22388996
Rheumatol Int. 2013 May;33(5):1259-64
pubmed: 23124693
Obes Rev. 2013 Mar;14(3):232-44
pubmed: 23171381
Curr Pain Headache Rep. 2013 Aug;17(8):356
pubmed: 23801009
Arthritis Res Ther. 2014;16(5):423
pubmed: 25606590
Curr Rheumatol Rev. 2015;11(1):15-17
pubmed: 26002453
Curr Rheumatol Rev. 2017;13(2):98-102
pubmed: 27655626
Arthritis Care Res (Hoboken). 2017 Aug;69(8):1282-1285
pubmed: 27768840
Arch Endocrinol Metab. 2017 May-Jun;61(3):249-256
pubmed: 28226002
Skeletal Radiol. 2017 Jun;46(6):837-840
pubmed: 28324118
Arthritis Care Res (Hoboken). 2017 Dec;69(12):1789-1798
pubmed: 28393498
Semin Nucl Med. 2017 Jul;47(4):408-424
pubmed: 28583280
BMC Musculoskelet Disord. 2017 Jul 7;18(1):294
pubmed: 28687081
JAMA. 2018 Apr 24;319(16):1723-1725
pubmed: 29570750
Cleve Clin J Med. 2018 May;85(5):367-376
pubmed: 29733785
J Rheumatol. 1985 Oct;12(5):980-3
pubmed: 3910836
Arthritis Rheum. 1995 Mar;38(3):369-73
pubmed: 7880191
Clin Exp Rheumatol. 1996 Mar-Apr;14(2):223-4
pubmed: 8737736
J Clin Endocrinol Metab. 1997 Dec;82(12):4196-200
pubmed: 9398739